TransMedics (TMDX) Receivables - Net (2018 - 2025)
TransMedics (TMDX) has 8 years of Receivables - Net data on record, last reported at $84.3 million in Q4 2025.
- For Q4 2025, Receivables - Net fell 13.75% year-over-year to $84.3 million; the TTM value through Dec 2025 reached $84.3 million, down 13.75%, while the annual FY2025 figure was $84.3 million, 13.75% down from the prior year.
- Receivables - Net reached $84.3 million in Q4 2025 per TMDX's latest filing, up from $80.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $142.0 million in Q1 2025 and bottomed at $4.1 million in Q3 2021.
- Average Receivables - Net over 5 years is $53.6 million, with a median of $54.1 million recorded in 2023.
- Peak YoY movement for Receivables - Net: plummeted 32.42% in 2021, then soared 430.96% in 2022.
- A 5-year view of Receivables - Net shows it stood at $5.9 million in 2021, then skyrocketed by 365.3% to $27.6 million in 2022, then skyrocketed by 130.26% to $63.6 million in 2023, then soared by 53.71% to $97.7 million in 2024, then dropped by 13.75% to $84.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $84.3 million in Q4 2025, $80.7 million in Q3 2025, and $104.9 million in Q2 2025.